書籍詳細

序論

P.6 掲載の参考文献

• 1) Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, et al.:Telornerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol 59:307-315, 1994.
  pubmed

• 2) Hayflick L, Moorhead PS:The serial cultivation of human diploid cell strains. Exp. cell Res. 25:585-621, 1961.
  pubmed

• 3) Olovnikov AM:[Principle of marginotomy in template synthesis of polynucleotides] Dokl. Akad. Nauk. Sssr. 201:1496-1499, 1971 (Russian) .
  pubmed

• 4) Watson JD:Origin of concatameric T7 DNA. Nature New Biol. (London) 239:197-201, 1972.

• 5) Blackburn EH, Gan JG:A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 120:33-53, 1978.

• 6) Ide T, Tsuji Y, Nakashima T, Ishibashi S:Progress of aging in human diploid cells transformed with a tsA mutant of simian virus 40. Exp. cell Res. 150:321-328, 1984.
  pubmed

• 7) Greider CW, Blackburn EH:Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. cell 43:405-413, 1985.
  pubmed

• 8) Cooke HJ, Smith BA:Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb. Symp. Quant Biol. 51:213-219, 1986.

• 9) Pereira-Smith OM, Smith JR:Genetic analysis of indefinite division in human cells:Identification of four complementation groups. Proc. Natl. Acad. Sci. USA 85:6042-6046, 1988.
  pubmed

• 10) Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, et al.:A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85:6622-6626, 1988.
  pubmed

• 11) Greider CW, Blackburn EH:A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337, 1989.
  pubmed

• 12) Morin GB:The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. cell 59:521-529, 1989.
  pubmed

• 13) Allshire RC, Dempster M, Hastie ND:Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 17:4611-4627, 1989.

• 14) Harley CB, Futcher AB, Greider CW:Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460, 1990.
  pubmed

• 15) Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, et al.:Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
  pubmed

• 16) Shay JW, Percira-Smith OM, Wright WE:A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33-39, 1991.

• 17) Harley CB:Telomere loss:mitotic clock or genetic time bomb? Mutat. Res. 256:271-282, 1991

• 18) Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y:Length of telomeric repeats in neuroblastoma:Correlation with prognosis and other biological characteristics. Jpn. J. Cancer Res. 83:159-164, 1992
  pubmed

• 19) Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, et al.:Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-1929, 1992
  pubmed

• 20) Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, et al.:Alteration in length of telomeric repeats in lung cancer. Lung Cancer 11:29-41, 1994
  pubmed

• 21) Kim NW, Piatyszek MA, Prowse KR, Harey CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994

• 22) Collins K, Kobayashi R, Greider CW:Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. cell 81:677-686, 1995.
  pubmed

• 23) Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, et al.:Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1:249-255, 1995.
  pubmed

• 24) Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al.:Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods cell Sci. 17:1-15, 1995.

• 25) Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S:telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320, 1995.
  pubmed

• 26) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, et al.:telomerase activity m small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902, 1995.

• 27) Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, et al.:Telomerase activity in human liver tissues:comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55:2734-2736, 1995.
  pubmed

• 28) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

• 29) Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR:Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240-4248, 1995.
  pubmed

• 30) Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, et al.:The RNA component of human telomerase . Science 269:1236-1241, 1995.
  pubmed

• 31) Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, et al.:Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn. J. Cancer Res. 86:899-904, 1995.
  pubmed

• 32) Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartoreni AC, et al.:Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92:12343-12346, 1995.

• 33) Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, et al.:A human telomeric protein. Science 270:1663-1667, 1995.
  pubmed

• 34) Hiyama E, Gonahon L, Kataoka T, Kuroi K, Yokoyama T, et al.:telomerase activity in human breast tumors. J. Natl Cancer Inst. 88:116-122, 1996.

• 35) Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, et al.:Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106:759-765, 1996.
  pubmed

• 36) Holt SE, Wright WE, Shay JW:Regulation of telomerase activity in immortal cell lines. Mol. cell. Biol. 16:2932-2939, 1996.
  pubmed

• 37) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:Telomerase activity in human intestine. Int. J. Onc. 9:453-458, 1996.

• 38) Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, et al.:A novel quantitative'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 13:2265-2274, 1996.

• 39) Kyo S, Takakura M, Kohama T, Inoue M:Telomerase activity in human endometrium. Cancer Res. 57:610-614, 1997.
  pubmed

• 40) Harrington L, McPhail T, Mar V, Zhou W, OultonR, et al.:A mammalian telomerase-associated protein. Science 275:973-977, 1997.
  pubmed

• 41) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLP1:a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997.
  pubmed

• 42) van Steensel B, de Lange T:Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743, 1997.
  pubmed

• 43) Ohyashiki K, Ohyashiki JH, Nishimaki J, ToyamaK, Ebihara Y, et al.:Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 57:2100-2103, 1997.

• 44) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, and rews WH, et al.:Telomerase catalytic subunit homologs from fission yeast and human . Science 277:955-959, 1997.

• 45) Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
  pubmed

• 46) Blasco MA, Lee HW, H and e MP, Samper E, Lansdorp PM, et al.:Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34, 1997.

• 47) Broccoli D, Smogorzewska A, Chong L, de LT:Human telomeres contain two distinct Myb-related proteins, TRFI and TRF2. Nat. Genet. 17:231-235, 1997.

• 48) Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, et al.:Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17:236-239, 1997.
  pubmed

• 49) Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17:498-502 , 1997.
  pubmed

• 50) Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al.:Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352, 1998.
  pubmed

• 51) van Steensel B, Smogorzewska A, de Lange T:TRF2 protecs human telomeres from end-to-end fusions. cell 92:401-413, 1998.

• 52) Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, et al.:Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574, 1998.
  pubmed

• 53) Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, et al.:Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp. Cell Res. 216:101-106, 1995.

• 54) Nakamura TM, Cech TR:Reversing time:origin of telomerase. Cell 92:587-590, 1998.
  pubmed

• 55) Shay JW, Bacchetti S:A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-791, 1997.
  pubmed

• 56) Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, et al.:telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1:1245-1251, 1995.
  pubmed

• 57) Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, et al.:Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 57:2373-2377, 1997.
  pubmed

• 58) Harle-Bachor C, Boukamp P:Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93:6476-6481, 1996.
  pubmed

• 59) Holt SE, Aisner DL, Shay JW, Wright WE:Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA 94:10687-0692, 1997.
  pubmed

• 60) Bryan TM, Englezou A, Dalla PL, Dunham MA, Reddel RR:Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-1274, 1997.

• 61) McEachern MJ, Blackburn EH:Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376:403-409, 1995.
  pubmed

• 62) Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, et al.:Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:661-667, 1993.
  pubmed

• 63) Wright WE, Shay JW:Telomere positional effects and the regulation of cellular senescence. TIG 8:193-197, 1992.
  pubmed

• 64) Yasui W, Tahara E:telomerase and cancer. The Fifth International Symposium of the Hiroshima Cancer Seminar October 1995, Hiroshima, Japan. J. Cancer Res. Clin. Oncol. 122:770-773, 1996.
  pubmed

• 65) Breslow RA, Shay JW, Gazdar AF, Srivastava S:Telomerase and early detection of cancer:a National Cancer Institute workshop. J. Natl. Cancer Inst. 89:618-623, 1997.
  pubmed

• 66) Lundblad V, Wright WE:Telomeres and telomerase:a simple picture becomes complex. cell 87:369-375, 1996.
  pubmed

• 67) Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffmann AR:Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168-4172, 1998.

• 68) Naito T, Matsuura A, Ishikawa F:Circular chromosome formation in a fission yeast mutant defective in two ATM homologues. Nat. Genet. 20:203-206, 1998.

• 69) Nakamura TM, Cooper JP, Cech TR:Two modes of survival of fission yeast without telomerase . Science 282:493-496, 1998.
  pubmed

• 70) Smith S, Giriat I, Schmitt A, de Lange T:Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science 282:1484-1487, 1998.
  pubmed

• 71) Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, et al.:Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21:111-114, 1999

I. 基礎

P.20 掲載の参考文献

• 1) 井出利憲:ヒト細胞の老化と不死化(単著). 羊土社, 1994.

• 2) Counter CM:The roles of telomeres and telomerase in cell life span. Mut. Res. 366:45-63, 1996.

• 3) Shay JW, Bacchetti S:A survey of telomerase activity in human cancer. Eur. J. Cancer 33:787-791, 1997.
  pubmed

• 4) Hayflick L, Moorehead PS:The serial cultivationof human diploid cell strains. Exp. cell Res. 25:585-621, 1961.

• 5) Martin GM, Sprague CA, Epstein CJ:Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab. Invest. 23:86-92, 1970.
  pubmed

• 6) Goldstein S:生物学的老化の早期開始ならびに亢進性の特徴をもつヒト遺伝疾患, in The genetics of Aging(訳:老化の遺伝性生化学) . Schneider EL ed. 東京大学出版会, 1981, p171-230.

• 7) Makarpv VL, Hirose Y, Langmore JP:Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666, 1997.

• 8) Harley CB, Futcher AB, Greider CW:Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460, 1990.
  pubmed

• 9) Allsopp RC, Vaziri H, Petterson C, Goldstein S, Younglai EV, et al.:Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89:10114-10118, 1992.

• 10) Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, et al.:Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1921-1929, 1992.
  pubmed

• 11) Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC:Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
  pubmed

• 12) Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ:In vivo loss of telomeric repeats with age in human s. Mut. Res. 256:45-48, 1991.

• 13) Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, et al.:Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:661-667, 1993.
  pubmed

• 14) Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, et al.:Accelerated loss of telomeric repeats may not explain eccelerated replicative decline of Werner syndrome cells. Hum. Genet. 97:750-754, 1996.

• 15) Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, et al.:Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15:1911-1920, 1997.
  pubmed

• 16) von Zglinicki T, Seretzki G, Docke W, Lotze C:Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts:a model for senescence? Exp. Cell Res. 220:186193, 1995.

• 17) Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR:Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98, 1994.
  pubmed

• 18) Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, et al.:Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747, 1996.
  pubmed

• 19) Tahara H, Sato E, Noda A, Ide T:Increase in expression of p21 sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10:835-840, 1995.

• 20) Tresini M, Mawal-Dewan M, Cristofalo VJ, Sell C:A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts. Cancer Res. 58:1-4, 1998.

• 21) Ogryzko VV, Hirai TH, Russanova VR, Barbie DA, Howard BH:Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. J Mol. Cell. Biol. 16:5210-5218, 1996.

• 22) Venable ME, Lee JY, Smyth MJ, Bielawska A. Obeid LM:Role of ceramide in cellular senescence. J. Biol. Chem. 270:30701-30708, 1995.
  pubmed

• 23) Robles SJ, Adami, GR:Agents that cause DNA double strand breaks lead to p16 INK 4a enrichment and the premature senescence of human fibroblasts. Oncogene 16:1113-1123, 1998.

• 24) Yu C, Oshima J, Fu YH, Wijsman EM, Hisama F, et al.:Positional cloning of the Werner's syndromegene. Science 272:258-262, 1996.

• 25) Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, et al.:The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83:655-666, 1995.
  pubmed

• 26) Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, et al.:A signal ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995
  pubmed

• 27) Ide T, Tsuji Y, Nakashima T, Ishibashi S:Progress of aging in human diploid cells transformed with a tsA mutant of simian virus 40. Exp. Cell Res. 150:321-328, 1984.
  pubmed

• 28) Shay JW, Wright WE, Werbin H:Defining the molecular mechanisms of human cell immortalizaion. Biochim. Biophys. Acta 1072:1-7, 1991.
  pubmed

• 29) Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, et al.:The RNA component of human telomerase . Science 269:1236-1241, 1995.
  pubmed

• 30) Blasco MA, Funk W, Villeponteau B, Greider CW:Functional characterization and developmental regulation of mouse telomerase RNA. Science 269:1267-1270, 1995.
  pubmed

• 31) Nakamura TM, Mori GB, Chapman KB, Weinrich SL, Andrews WH, et al.:Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.

• 32) Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
  pubmed

• 33) Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, et al.:Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11:3109-3115, 1997.
  pubmed

• 34) Nakayama J, Tahara H, Tahara E, Saito M, Ito Ket al.:Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18:65-68, 1998.

• 35) Weinrich SL, Pruzan R, Ma L, Ouenette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17:498-502, 1997.

• 36) Bodnar AG, Ouenette M, Frolkis M, Holt SE, Chin CP, et al.:Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352, 1998.

• 37) Tokutake K, Matsumoto T, Watanabe T, Maeda S, Tahara H, et al.:Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247:765-772, 1998.

P.32 掲載の参考文献

• 1) Zakian VA:Telomeres:beginning to understand the end. Science 270:1601-1607, 1995.
  pubmed

• 2) Klobutcher LA, Swanton MT, Donini O, Prescott DM:An gene sized DNA molecules in four species of hypotrichs have the same terminal sequence and an unusual 3'terminus. Proc. Natl. Acad. Sci. USA 78:3015 3019, 1981.

• 3) Henderson E, Blackburn EH:An overhang 3' terminus is a conserved feature of telomeres. Mol. Cell Biol 9:345-348, 1989.
  pubmed

• 4) Wellinger RJ, Wolf AJ, Zakian VA:Saccharomyces Telomeres acquire single-strand TG1-3 tails late in S phase. Cell 72:51-60, 1993.

• 5) Weninger RJ. Ethier K, Labrecque P, Zakian VA:Evidence for a few step in telomere maintenance. Cell 85:423-433, 1996.

• 6) McElligott R, Wellinger RJ:The terminal DNA structure of mammalian chromosomes. EMBO J. 16:3705-3714, 1997.
  pubmed

• 7) Makarov VL, Hirose Y, Langmore JP:Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666, 1997.

• 8) Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW:Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11:2801 2809, 1997.

• 9) Fang G, Gray JT, Cech TR:Oxytricha telomerebinding protein:Separable DNA-binding and dimerization domains of the a subunit. Genes Dev. 7:870-882, 1993.
  pubmed

• 10) Price CM:Telomere structure in Euplotes crassus:Characterization of DNA-protein interactions and isolatiom of a telomere-binding protein. Mol. Cell Biol 10:3421-3431, 1990.
  pubmed

• 11) Cardenas ME, Bianchi A, De Lange T:A Xenopus egg factor with DNA-binding properties characteristic of terminus-specific telomeric proteins. Genes Dev. 7:883894, 1993.

• 12) Nugent CI, Hughes TR, Lue NF, Lundblad V:Cdc13p:a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science 274:249-252, 1996.
  pubmed

• 13) Fang G, Cech TR:The beta subunit of Oxytricha telomere-binding protein promotes G-quartet formation by telomeric DNA. Cell 74:875. 885, 1993.

• 14) Giraldo R, Rhodes D:The yeast telomere-binding protein RAP1 binds to and promotes the formation of DNA quadruplexes in telomeric DNA. EMBO J. 13:2411-2420, 1994.
  pubmed

• 15) Brun C, Marcand S, Gilson E:Proteins that bind to double-stranded regions of telomeric DNA. Trends Cell Biol. 7:317-323, 1997.

• 16) Lingner J, Cooper JP, Cech TR:telomerase and DNA end replication:no longer a lagging strand problem? Science 269:1533-1534, 1995.
  pubmed

• 17) Greider CW, Blackburn EH:Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413, 1985.
  pubmed

• 18) Greider CW, Collins K, Autexier C:Tlomerases. In DNA Replication in Eukaryotic Cells. (DePamphilis ML ed. ), Cold Spring Harbor Laboratory Press, New York, 1996, p619-638.

• 19) Greider CW, Blackburn EH:A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337, 1989.
  pubmed

• 20) Romero DP, Blackburn EH:A conserved secondary structure for telomerase RNA. Cell 67:343-353, 1991.
  pubmed

• 21) Lingner J, Hendrick LL, Cech TR:telomerase RNAs of different ciliates have a common secondary structure and a permuted template. Genes Dev. 8:1984-1998, 1994.

• 22) McCormick-Graham M, Romero DP:Ciliate telomerase RNA structural features. Nucleic Acids Res. 23:1091-1097, 1995.
  pubmed

• 23) Bhattacharyya A, Blackburn EH:A functional telomerase RNA swap in vivo reveals the importance of nonetemplate RNA domains. Proc. Natl. Acad. Sci. USA 94:2823-2827, 1997.
  pubmed

• 24) Singer MS, Gottschling DE:TLC1:Template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409, 1994.
  pubmed

• 25) McEachern M, Blackburn EH:Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376:403-409, 1995.
  pubmed

• 26) Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, et al.:The RNA component of human telomerase. Science 269:1236 1241, 1995.

• 27) Blasco MA, Funk W, Villeponteau B, Greider CW:Functional characterization and developmental regulation of mose telomerase RNA. Science 269:1267-1270, 1995.

• 28) Autexier C, Pruzan R, Funk WD, Greider CW:Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J. 15:5928-5935, 1996.
  pubmed

• 29) Beattie TL, Zhou W, Robinson MO, Harrington L:Reconstitution of human telomerase activity in vitro. Curr. Biol. 8:177-180, 1998.
  pubmed

• 30) Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR:Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567, 1997.
  pubmed

• 31) Lingner J, Cech TR:Purification of telomerase from Euplotes aediculatus:requirement of a primer 3' overhang. Proc. Natl. Acad. Sci. USA 93:10712-10717, 1996.
  pubmed

• 32) Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V:Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144:1399-1412, 1996.
  pubmed

• 33) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, and rews WH, et al.:telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.

• 34) Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
  pubmed

• 35) Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, et al.:Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:2011-2019, 1997.
  pubmed

• 36) Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, et al.:human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11:3109-3115, 1997.
  pubmed

• 37) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18:65-68, 1998.
  pubmed

• 38) Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA:Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16:1723-1730, 1998.
  pubmed

• 39) Bryan TM, Sperger JM, Chapman KB, Cech TR:Telomerase reverse transcriptase genes identified in Tetrhymena thermophila and Oxytricha trifallax. Proc. Natl Acad. Sci. USA 95:8479-8484, 1998.
  pubmed

• 40) Collins K, Gandhi L:The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. Proc. Natl. Acad. Sci. USA 95:8485-8490, 1998
  pubmed

• 41) Weinrich SL, Pruzan R, Ma L, Ouenette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17:498-502, 1997.

• 42) Eickbush TH:Telomerase and retrotransposons:which came first? Science 277:911-912, 1997.
  pubmed

• 43) Nakamura TM, Cech TR:Reversing time:origin of telomerase. Cell 92:587-590, 1998.
  pubmed

• 44) Collins K, Kobayashi R, Greider CW:Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. cell 81:677-686, 1995.
  pubmed

• 45) Ghandi L, Collins K:Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomerc DNA substrates. Genes Dev. 12:721-733, 1998.

• 46) Harrington L, McPhail T, Mar V, Zhou W, Oulton R, et al.:A mammalian telomerase-associated protein. Science 275:973-977, 1997.
  pubmed

• 47) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLP1:a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997.
  pubmed

• 48) Schnapp G, Rodi H-P, Rettig WJ, Schnapp A, Damm K:One step affinity purification protocol for human telomerase. Nucleic Acids Res. 26:3311-3313, 1998.
  pubmed

• 49) Lingner J, Cech TR, Hughes TR, Lundblad V:Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc. Natl. Acad. Sci. USA 94:11190-11195, 1997.
  pubmed

• 50) Lin JJ, Zakian VA:An in vitro assay for Saccharomyces telomerase requires EST1. Cell 81:1127-1135, 1995.

• 51) Steiner BR, Hidaka K, Fuher B:Association of the Est1 protein with telomerase activity in yeast. Proc. Natl. Acad. Sci. USA 93:2817-2821, 1996.

• 52) Virta-Pearlman V, Morris DK, Lundblad V:Est1 has the properties of a single-stranded telomere end-binding protein. Genes Dev. 10:3094-3104, 1996.
  pubmed

• 53) Morris DK, Lundblad V:Programmed translational frameshifting in a gene required for yeast telomere replication. Curr. Biol. 7:969-976, 1997.

• 54) Biessmann H, Mason JM:Telomere maintenance without telomerase. Chromosoma 106:63-69, 1997.
  pubmed

• 55) Bryan TM, Reddel RR:Telornere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer 33:767-773, 1997
  pubmed

P.45 掲載の参考文献

• 1) Blackburn EH:Structure and functions of telomeres. Nature 266:569-573, 1991.

• 2) Konig P, Rhodes D:Recognition of telomeric DNA. Trends Biochem. Sci. 22:43-47, 1997.
  pubmed

• 3) Chiu C-P, Harley CB:Replicative senescence and cell immortality:The role of telomeres and telomerase. Proc. Soc. Exp. Biol. Med. 214:99-106, 1997.
  pubmed

• 4) Autexier C, Greider CW:Telomerase and cancer:revisiting the telomere hypothesis. Trends Biochem. Sci. 21:387-391, 1996.
  pubmed

• 5) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
  pubmed

• 6) Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
  pubmed

• 7) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al.:Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.
  pubmed

• 8) Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, et al.:Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:2011-2019, 1997.

• 9) Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, et al.:Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11:3109-3115, 1997.

• 10) Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, et al.:The RNA component of human telomerase. Science 269:1236-1241, 1995.
  pubmed

• 11) Weinrich SL, Pruzan R, Ma L, Ouenette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17:498-502, 1997.

• 12) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18:65-68, 1998.
  pubmed

• 13) Ramakrishnan S Eppenberger U, Mueller H, Shinkai Y, Narayanan R:Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58:622-625, 1998.
  pubmed

• 14) Wang J, Xie LY, Anan S, Beach D, Halmorl GJ:Myc activates telomerase. Genes Dev. 12:1769-1774, 1998.

• 15) Klingelhutz AJ, Foster SA, McDougan JK:telomerase activation by the E6 gene product of human papinomavirus type 16. Nature 380:79-82, 1996.

• 16) Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, etal.:Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15:2589-2596, 1997.
  pubmed

• 17) Horikawa I, Oshirnura M, Barrett JC:Repression of the telomerase catalytic subunit by a gene on human:chromosome 3 that induces cellular senescence. Mol. Carcinog. 22:65-72, 1998.

• 18) Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, et al.:Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet. 19:182-186, 1998.

• 19) Ku WC, Cheng AJ, Wang TC:Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem. Biophys. Res. Commun. 241:730-736, 1998.

• 20) Li H, Zhao n, Funder JW, Liu JP:Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272:16729-16732, 1997.

• 21) Bodnar AG, Ouenette M, Frolkis M, Holt SE, Chiu CP, et al.:Extension of life-spam by introduction of telomerase into normal human cells. Science 279:349-352, 1998.

• 22) Blasco MA, Rizen M, Greider CW, Hanahan D:Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12:200-204, 1996.
  pubmed

• 23) Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, et al.:Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013. 1021, 1997.

• 24) Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H:Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol. Carcinog. 21:26 36, 1998.

• 25) Albanell J, Han W, Menado B, Gunawardane R, Scher HI, et al.:Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res. 56:1503-1508, 1996.

• 26) Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT:Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:3796-3802, 1996.
  pubmed

• 27) Zhao J. Q, Hoare SF, McFarlane R, Muir S, Parkinson EK, et al.:Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 16:1345-1350, 1998.
  pubmed

• 28) Counter CM, Meyerson M, Eaton EN, Weinberg RA:The catalytic subunit of yeast telomerase . Proc. Natl. Acad Sci. USA 94:9202-9207, 1997.
  pubmed

• 29) Lingner J, Cech TR:Telomerase and chromosome end maintenance. Curr. Opin. Genet. Dev. 8:226-232, 1998.
  pubmed

• 30) Nugent CI, Lundblad V:The telomerase reverse transcriptase:components and regulation. Genes Dev. 12:1073-1085, 1998.
  pubmed

• 31) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa, F:TLP1:A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. cell 88:875-884, 1997.
  pubmed

• 32) Oshimura M, Barrett JC:Multiple pathways to cellular senescence:Role of telomerase repressors. Eur. J. Cancer 33:710-715, 1997.
  pubmed

• 33) Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, et al.:Evidence for a putative telomerase repressor gene on the 3p14. 2-p21. 1 region. Genes Chromosomes Cancer 23:123-133, 1998,
  pubmed

• 34) Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, et al.:Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 14:1955-1964, 1997.
  pubmed

• 35) Bryan TM, Englezou A, Dana-Pozza L, Dunham MA, Reddel RR:Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-1274, 1997.

• 36) Lustig AJ:Mechanisms of silencing in Saccharomyces cerevisiae. Curr. Opin. Genet. Dev. 8:233-239, 1998.
  pubmed

• 37) Broccoli D, Smogorzewska A, Chong L, de Lange T:Human Telomeres contain two distinct Myb-related proteins, TRFI and TRF2. Nat. Genet. 17:231-235, 1997.

• 38) Marcand S, Gilson E, Shore D:A protein-counting mechanism for telomere length regulation in yeast. Science 275:986-990, 1997.

• 39) Cooper JP, Nimmo ER, Allshire RC, Cech, TR:Regulation of telomere length and function by a Myb-domain protein in fission yeast. Nature 385:744-747, 1997.
  pubmed

• 40) van Steensel B, de Lange T:Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743, 1997.
  pubmed

• 41) Jones CJ, Soley A, Skinner JW, Gupta J, Haughton MF, et al.:Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp. Cell Res. 240:333-339, 1998.
  pubmed

• 42) Nimmo ER, Pidoux AL, Perry PE, Allshire RC:Defective meiosis in telomere-silencing mutants of Schizosaccharomyces pombe. Nature 392:825 828, 1998.

• 43) Cooper JP, Watanabe Y, Nurse P:Fission yeast Tazl protein is required for meiotic telomere clustering and recombination. Nature 392:828-831, 1998.
  pubmed

• 44) Griffith J, Bianchi A, de Lange T:TRF1 promotes paranel pairing of telomeric tracts in vitro. J. Mol. Biol. 278:79-88, 1998.
  pubmed

• 45) Shen M, Haggblom C, Vogt M, Hunter T, Lu KP:Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggests a role in mitosis. Proc. Natl. Acad. Sci. USA 94:13618-13623, 1997.
  pubmed

• 46) van Steensel B, Smogorzewska A, de Lange T:TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413, 1998.
  pubmed

• 47) Nugent CI, Hughes TR, Lue NF, Lundblad V:Cdc13p:a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science 274:249-252, 1996.
  pubmed

• 48) LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot, B:Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat. Genet. 19:199-202, 1998.

• 49) Laroche T, Martin SG, Gotta M, Gorham HC, Pryde FE, et al.:Mutation of yeast Ku genes disrupts the subnuclear organization of telomeres. Curr. Biol. 8:653-656, 1998.
  pubmed

• 50) Nugent CI, Bosco G, Ross LO, Evans SK, Salinger AP, et al.:Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8:657-660, 1998
  pubmed

• 51) Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, et al.:TEL1, a gene involved in controning telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82:823-829, 1995.

• 52) Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR:Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168-4172, 1998.
  pubmed

• 53) Li H, Zhao L, Yang Z, Funder JW, Liu JP:Telomerase is controlled by protein kinase Cα in human breast cancer cells. J. Biol. Chem. 273:33436-33442, 1998.

• 54) Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, et al.:Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J. Natl. Cancer Inst. 91:37-45, 1999.

• 55) Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, et al.:Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:551-557, 1999.
  pubmed

• 56) Horikawa I, Cable PL, Afshari C, Barrett JC:Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59:826-830, 1999.
  pubmed

• 57) Cong YS, Wen J, Bacchetti S:The human telomerase catalytic subunit hTERT:organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8:137-142, 1999.
  pubmed

• 58) Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, et al.:Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionany equivalent in cellular transformation. Oncogene 18:1219-1226, 1999.

• 59) Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ:Both Rb/p16 INK 4a inactivation and telomerase activity are required to immortalize human epityhelial cells. Nature 396:84-88, 1998

P.58 掲載の参考文献

• 1) Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, et al.:The RNA component of human telomerase . Science 269:236-1241, 1995.

• 2) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLP1:a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997,
  pubmed

• 3) Harrington L, McPhail T, Mar V, Zhou W, OultonR, et al.:A mammalian telomerase-associated protein. Science 275:937-977, 1997,

• 4) Nakamura TM, Morin GB, Chapman KB, Weirich SL, Andrews WH, et al.:Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.

• 5) Meyerson M, Counter CM, Eaton EN, Ellison LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.

• 6) Weinrich SL, Pruzan R, Ma L, Ouenette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17:498-502, 1997.

• 7) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:Telomerase activation by hTRT in human normal fibroblast and hepatocellular carcinomas. Nature Genet. 18:65-68, 1998.
  pubmed

• 8) Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, et al.:Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16:1217-1222, 1998.
  pubmed

• 9) Ramakrishnan S, Eppenberger U, Muller H, Shinkai Y, Narayanan R:Expression profile of the catalytic subunit of the telomerase gene. Cancer Res. 58:622-625, 1998.

• 10) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

• 11) Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 219:649-655, 1996.
  pubmed

• 12) Weng NP, Levine BL, June CH, Hodes RJ:Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:2471-2479, 1996.

• 13) Buchkovich, KJ, Greider CW:Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell. 7:1443-1454, 1996.

• 14) Bodnar AG, Kim NW, Effros RB, Chiu CP:Mechanism of telomerase induction during T cell activation. Exp. Cell. Res. 228:58-64, 1996.

• 15) Yamada O, motoji T, Mizoguchi H:Up-regulation of telomerase activity in human lymphocytes. Biochem, Biophys. Acta 1314:260-266, 1996.
  pubmed

• 16) Weng NP, Levine BL, June CH, Hodes RJ:Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J. Immunol. 158:3215-3220, 1997.

• 17) Igarashi H, Sakaguch N:Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299-1307, 1997.

• 18) Hu BT, Lee SC, Marin E, Ryan DH, Insel RA:Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J. Immunol. 159:1068-1071, 1997.
  pubmed

• 19) Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak T, et al.:Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J. Exp. Med. 183:329-334, 1996.

• 20) Metcalf JA, Parkhill J, Campbell L, Stacey M, Biggs P, et al.:Accelerated telomerase shortening in ataxia telangiectasia. Nature Genet. 13:350-353, 1996.

• 21) Beamish H, Williams R, Chen P, Khanna KK, Hobson K, et al.:Rapamycin resistance in ataxia-telangiectasia. Oncogene 13:963-970, 1996.
  pubmed

• 22) Murata K, Wu J, Brautigan DL:B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl Acad. Sci. USA 94 10624-10629, 1997.

• 23) Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, et al.:Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92:1-9, 1998.

• 24) Li H, Zhao LL, Funder JW, Liu Jp:Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J, Biol. Chem. 27:16729-16732, 1997.

• 25) Mizukami Y, Hirata T, Yoshida K:Nuclear translocation of PKC zeta during ischemia and its inhibition by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. FEBS Lett. 401:247-251, 1997.
  pubmed

• 26) Akimoto K, Takahashi R, Moriya S, Nishioka N, Takayanagi J, et al.:EGF or PDGF receptors activate atypical PKC lambda through phos-phatidylinositol 3-kinase, EMBO J. 15:788-798, 1996.
  pubmed

• 27) 清宮啓之, 鶴尾 隆:白血球細胞の分化誘導に伴うテロメラーゼ活性のダウンレギュレーション. 日本臨床 56:29-33, 1998.

• 28) Norrback KF, Dahlenborg K, Carlsson R, Roos G:Telomerase activation in normal B lymhocytes and non-Hodgkin's lymphomas. Blood 88:222-229, 1996.

• 29) Frenck Tr RW, Blakburn EH, Shannon KM:The rate of telomerase sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA 95:5607-5610, 1998

P.72 掲載の参考文献

• 1) Watson JD:Origin of concatemeric T7 DNA. Nature NB 239:197-201, 1972.

• 2) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
  pubmed

• 3) Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, et al.:Telomerase activity in normal human epithelial cells. Oncogene 13:433-439, 1996.
  pubmed

• 4) Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S:Telomerase activity in a specific cell subset co-expressing integrin β1/EGFR but not p75NGFR/bc12/integrin β4 in normal human epithelial cells. Oncogene 17:187-197, 1998.

• 5) Harle-Bachor C, Boukamp P:Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93:6476-6481, 1996.
  pubmed

• 6) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:Telomerase activity in human intestine. Int. J. Oncology 9:453-458, 1996.

• 7) Kyo S, Takakura M, Kohama T, Inoue M:Telomerase activity in human endometrium. Can-cer Res. 57:610-614, 1997.

• 8) Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R:Telomerase activity in normal human endothelial cells. Anticancer Res. 17:827-832, 1997.
  pubmed

• 9) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

• 10) Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S:Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 58:2315-2320, 1995.

• 11) Chiu C-P, Dragowska W, Kim NW, Vaziri H, Thomas TE, et al.:Differential expression of telomerase activity in he1TlatoPoietic progenitors from adult human bone marrow. Stem Cells 14:239-248, 1996.
  pubmed

• 12) Barrandon Y, Green H:Three clonal types of keratinocytes with different capacities for multiplication. Proc. Natl. Acad. Sci. USA 84:2302-2306, 1987.
  pubmed

• 13) Jones PH, Watt FM:Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73:713-724, 1993.
  pubmed

• 14) Jones PH, Harper S, Watt FM:Stem cell patterning and fate in human epidermis. Cell 80:83-93, 1995.

• 15) Morrison SJ, Shah NM, Anderson DJ:Regulatory mechanisms in stem cell Biology. Cell 88:287-298, 1997.
  pubmed

• 16) Ohta Y, Tsutsnmi K, Kikuchi K, Yasumoto S:Two distinct human uterine cervical epithelial cell lines that were established after transfecting human papinomavirus 16 DNA. JPn. J. Cancer Res. 99:644-651, 1997.

• 17) Loeffler M, Potten CS:Stem cells and cellular pedigress-a conceptual introduction. Stem cells (ed. Potten CS) , Academic Press, London, 1997, p1-27.

• 18) Weinrich SL, Pruzan R, Ma L, Ouenette M, Tesmer VM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Na. Gerlet. 17:498-502, 1997.

• 19) Sharma HW, Sckoloski JA, Perez JR, Maltese JY, Sartoreni AC, et al.:.:Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92:12343-12346, 1995.

• 20) Bestilny L, Brown CB, Miura Y, Robertson LD, Riabowol KT:Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:3796-3802, 1996.
  pubmed

• 21) Holt SE, Wright WE, Shat JW:Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol 16:2932-2939, 1996.

• 22) Albannell J, Han W, Mellando B, Gunawardane R, Scher HI, et al.:Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res. 56:1503-1508, 1996.

• 23) Morrison SJ, Uchida N, Weissman LL:The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35-71, 1994.

• 24) Cotsarelis G, Sun T-T, Lavker RM:Label-retaining cells reside in bulge area of pilosebaceous unit:implication for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61:1327-1337, 1990.

• 25) Rhyu MS, Jan LY, Jan YN:Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells, Cell 76:477-491, 1994.
  pubmed

• 26) Jan YN, Jan LY:Asymmetric cell division. Nature 392:775-778, 1998.
  pubmed

• 27) Zhong WM, Feder JN, Jiang MM, Jan LY, Jan YN:Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis. Neuron 17:43-53, 1996.

• 28) Kobayashi K, Rochat A, Barrandon Y:Segregation of keratinocyte colony-forming cells in the bulge of the rat vibrissa. Proc. Natl. Acad. Sci. USA 90:7391-7395, 1993.
  pubmed

• 29) Rochat A, Kobayashi K, Barr and on Y:Location of stem cells of human hair fonicles by clonal analysis. Cell 76:1063-1073, 1994.

II. 測定法

P.86 掲載の参考文献

• 1) Zakian VA:Structure and function of telomeres. Annu. Rev. Genet. 23:579-604, 1989.
  pubmed

• 2) Moyzis R, Buckingham JM, Cram LS, Dani M, Deaven LL, et al.:A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85:6622-6626, 1988.
  pubmed

• 3) Allshire RC, Dempster M, Hastie ND:Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 17:4611-4627, 1989.

• 4) Harley CB:Telomere loss:mitotic clock or genetic time bomb? Mutation Res. 256:271-282, 1991.

• 5) Harley CB, Vaziri H, Counter CM, Allsopp RC:The telomere hypothesis of cellular aging. Exp. Gerontol. 27:375-382, 1992.
  pubmed

• 6) Broccoli D, Smogorzewska A, Chong L, de Lange T:Human telomere contain two distinct MYB-related proteins, TRFI and TRF2. Nature Genet. 17:231-235, 1997.

• 7) Bilaud T, Brun C, Abcelin K, Koering CE, Laroche T, et al.:Telomeric localization of TRF2, a novel human telobox protein. Nature Genet. 17:236-239, 1997.

• 8) Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, et al.:Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
  pubmed

• 9) Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y:Length of telomeric repeats in neur-oblastoma:Correlation with prognosis and other biological characteristics. Jpn. J. Cancer Res. 83:159-164, 1992.

• 10) Hiyama K, Shirotani Y, Ishioka S, Hiyama E, Yokoyama T, et al.:Cancer-cell proliferation and alteration in length of telomeric repeats. Tiss. Cult. Res. Commun. 12:291-297, 1993.

• 11) Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, et al.:Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10:937-944, 1995.
  pubmed

• 12) Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, et al.:Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. Oncol 1. 6:13-16, 1995.

• 13) Mehle C, Ljungberg B, Roos G:Telomere shortening in renal cell carcinoma. Cancer Res. 54:236-241, 1994.
  pubmed

• 14) Shay JW, Wright WE, Werbin H:Loss of telomeric DNA during aging may predispose cells. to cancer (Review). Int. J. Oncol. 3:559-563, 1993.

• 15) Levy MZ, Allsopp RC, Futcher B, Greider CW, Harley CB:Telomere end-replication problem and cell aging. J. Mol. Biol. 225:951-960, 1992.

• 16) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:Telomerase activity in human intestine. Int. J. Oncol. 9:453-458, 1996.

• 17) Bryant JE, Hutchings KG, Moyzis RK, Griffith JK:Measurement of telomeric DNA content in human tissues. Biotechniques 23:476-483, 1997.
  pubmed

• 18) de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, et al.:Structure and variability of human chromosome ends. Moll. Cell. Biol. 10:518-527, 1990.

• 19) Blackburn EH:telomerase s. Annu. Rev. Biochem. 61:113-129, 1992.

• 20) Makarov VL, Hirose Y, Langmore JP:Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666, 1997.

• 21) Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska Y, Little MT, et al.:Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5:685. 691, 1996.

• 22) Henderson S, Allsopp R, Spector D, Wang SS, Harley CB:In situ analysis of changes in telomere size during replicative aging and cell transformation. J. cell Biol. 134:1-12, 1996.

• 23) Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, et al.:Short telomeres on human chromosome 17p. Nature Genet. 18:76-80, 1998
  pubmed

P.93 掲載の参考文献

• 1) Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC:Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80:224-234, 1988.
  pubmed

• 2) Lansdorp PM, Verwoerd NP, van de Roiike FM, Dragowska V, Little M-T, et al.:Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5:685-691, 1996.

• 3) Zijlmans JM, Martens UM, Poon SS, Raap AK, Tanke HJ, et al.:Telomeres in the mouse have large inter-chromosomal variations in the number of T2 AG3 repeats. Proc. Natl. Acad. Sci. USA 94:7423-7428, 1997.

• 4) Freshney R I:Culture of Animal cells. A Manual of Basic Technique. 2nd ed. Alan R Liss, Inc., New York, 1987, p175-179.

• 5) Tokutake Y, Matsumoto T, Maeda S, Watanabe T, Tahara H, et al.:Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247:765-772, 1998.
  pubmed

• 6) Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, et al.:A human telomeric protein. Science 270:1663-1667, 1995.
  pubmed

• 7) Gosden J, Lawson D:Rapid chromosome identification by oligonucleotide primed in situ DNA synthesis(PRINS). Hum. Mol. Genet, 3:931-936, 1994.
  pubmed

• 8) Therkelsen AJ, Nielsen A, Koch J, Hindkjaer J, Kolvraa S:Staining of human telomeres with primed in situ labeling (PRINS). Cytogenet. Cell Genet. 68:115-118, 1995.
  pubmed

• 9) Musio A, Rainaldi G:Cycling-PRINS. A method to improve the accuracy of telomeric sequence detection in mammalian chromosomes. Mutant. Res. 390:1-4, 1997.

• 10) Gosden J:Rapid mapping of repeated DNA sequences to chromosomes by PRINS and cycling-PRINS. Am. Biotechnol. Lab. 12:58, 1994.
  pubmed

• 11) van Steensel B, Smogorzewska A, de Lange T:TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413, 1998.
  pubmed

• 12) Bryan TM, Reddel RR:Telomere dynamics and telomerase activity in in vitro-immortalized human cells. Eur. J. Cancer 33:767-773, 1997.

• 13) Murnane JP, Sabatier L, Marder BA, Morgan WF:Telomere dynamics in an immortal human cell line. EMBO Journal 13:4953-4962, 1994.

• 14) Niida H, Matsumoto T, Satoh H, Shiwa M, To-kutake Y et al.:Severe growth defect in mouse cells lacking the telomerase RNA component. Nature Genet. 19:203-1206, 1998.

• 15) Bodnar AG, Ouenette J, Frolkis M, Holt SE, Chiu, C-P, et al.:Extention of life-span by introduction of telomerase into normal human cells. Science 279:349-352, 1998.

• 16) Kiyono T, Foster SA, Koop JI, Mcdugall JK, Galloway DA, et al.:Both Rb/p16 INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88, 1998.

P.99 掲載の参考文献

• 1) Greider CW, Blackburn EH:Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413, 1985.
  pubmed

• 2) Morin GB:The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521-529, 1989.
  pubmed

• 3) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
  pubmed

• 4) Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al.:Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci. 17:1-15, 1995.

• 5) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:telomerase activity in human intestine. Int. J. Onc. 9:453-458, 1996.

• 6) Wright WE, Shay JW, Piatyszek MA:Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:3794-3795, 1995.
  pubmed

• 7) Holt SE, Norton JC, Wright WE, Shay JW:Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Meth. Cell Sci. 18:237-248, 1996.

• 8) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, et al.:Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902, 1995.
  pubmed

P.103 掲載の参考文献

• 1) Shay JW, Bacchetti S:A survey of telomerase activity in human cancer. Eur. J. Cancer 5:787-791, 1997.
  pubmed

• 2) Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, et al.::Clinical implications of telomerase activity level in acute leukemia. Clin. Can. Res. 3:619-625, 1997.
  pubmed

• 3) Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, et al.:Telomerase activity in lung cancer cells obtained from bronchial washings. J. Natl. Cancer Inst. 90:684-690, 1998.
  pubmed

• 4) Muller M, Heine B, Heicappell R, Ermich T, Hummel M, et al.:Telomerase activity in bladder cancer, bladder washings and urine. Int. J. Oncol. 9:1169-1173, 1996.

• 5) Hirose M, Abe-Hashimoto J, Ogura K, Tahara H, Ide T, et al.:Arapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repear amplification protocol. J. Cancer Res. Clin. Oncol. 123:337-344, 1997.

• 6) Ohyashiki JH, Ohyashiki K, Toyama K, Shay JW:A non-radioactive fluorescellce-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet. 12:395-396, 1996.

P.108 掲載の参考文献

• 1) Harley CB:Telomeres and ageing. in Telomeres. (eds. Blackburn EH, Greider CW), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1995, p247-263.

• 2) Shay JW, Gazdar AF:Telomerase in the early detection of cancer. J. Clin. Patho. 50:106-109, 1997.

• 3) Shay JW, Bacchetti S:A survey of telomerase activity in human cancer. Eur. J. Cancer 5:787-791, 1997.
  pubmed

• 4) Ohyashiki K, Ohyashiki JH, Nishimaki J, Toyama K, Ebihara Y, et al.:Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 57:2100-2103, 1997.

• 5) Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, et al.:Telomerase activity in lung cancer cells obtained from bronchial washings. J. Natl. Cancer Inst. 90:684 690, 1998.

• 6) Ohyashiki K, Yahata N, Ohyashiki JH, Iwamaa H, Hayashi S, et al.:A combilation of semiquantitative telomerase assay and in cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Cancer 83:2554 2560, 1998.

P.116 掲載の参考文献

• 1) Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, et al.:A novel quantitative stretch PCR assay that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 13:2265-2274, 1996.

• 2) Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M:Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int. J. Cancer 79:66-70, 1998.
  pubmed

• 3) Kyo S, Takakura M, Tanaka M, Murakami K, Saitoh R, et al.:Quantitative difference of telomerase activity among ovarian malignant and premalignant lesions. Clin, Cancer Res. 4:399-406, 1998.
  pubmed

P.135 掲載の参考文献

• 1) Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, et al.:Science 269:1236-1241, 1995.
  pubmed

• 2) Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, et al.:Cancer Res. 56:645-650, 1996.
  pubmed

• 3) Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, et al.:Jpn. J. Cancer Res. 88:103-107, 1997.
  pubmed

• 4) Harrington L, Zhou , V, McPhail T, Oulton R, Yeung DS, et al.:Genes. Dev. 11:3109-3115, 1997.

• 5) Meyerson M, Counter CM, Eaton EN, Enisen LW, Steiner P, et al.:cell 90:785-795, 1997,

• 6) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al.:Science 277:955959, 1997.

• 7) Harrington L, McPhail T, Mar V, Zhou W, Oulton R, et al.:Science 275:973-977, 1997.
  pubmed

• 8) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:Cell 88:875-884, 1997.
  pubmed

• 9) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:Nature Genet. 18:6568, 1998

• 10) Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, et al.:Nat. Genet. 19:182186, 1998.

• 11) Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama J, et al.:Jpn. J. Cancer Res. 89(11):1099-1103, 1998.
  pubmed

• 12) Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, et al.:Oncogene 18(8):561 1567, 1999.

• 13) Yasui W, Tahara E, Tahara H, Fujimoto J, Naka K, et al.:Jpn. J. Cancer Res. (in press)

III. ヒト正常細胞・癌細胞のテロメア長・テロメラーゼ活性

P.146 掲載の参考文献

• 1) Martin GM:Genetic modulation of telomeric terminal restriction-fragment length:relevance for clonal aging and late-life disease. Am J. Hum. Genet, 55:866-869, 1994.
  pubmed

• 2) Bodnar AG, Ouenette M, Frolkis M, Holt SE, Chiu CP, et al.:Extension of life-span by introductionof telomerase into normal human cells. Science 279:349-352, 1998.

• 3) Vaziri H, Benchimol S:Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:279-282, 1998.
  pubmed

• 4) Martin GM:Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth-Defects 14:5-39, 1978.

• 5) Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, et al.:Positional cloning of the Werner's syndrome gene. Science 272:258-262, 1996.
  pubmed

• 6) 名倉 潤:遺伝性早老症と老化遺伝子. BIO Clinica 13:134-139, 1998.

• 7) Oshima J, Brown WT, Martin GM:No detectable mutations at Werner helicase locus in progeria. Lancet 348:1106, 1996.
  pubmed

• 8) Smith JR, Pereira-Smith OM:Replicative senescence:implications for in vivo aging and tumor suppression. Science 273:63-67, 1996.
  pubmed

• 9) Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, et al.:Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl, Acad. Sci. USA 89:10114-10118, 1992.
  pubmed

• 10) Kruk PA, Rampino NJ, Bohr VA:DNA damage and repair in telomeres:relation to aging. Proc. Natl. Acad. Sci. USA 92:258-262, 1995.
  pubmed

• 11) Oshima J, Campisi J, Talmock TC, Martin GM:Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J. cell PhysioL 162:277-283, 1995.

• 12) Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, et al.:Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum. Genet. 97:750-754, 1996.

• 13) Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, et al.:Abnormal telomere dyliamics of B-lymphoblastoid ce11 strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15:1911-1920, 1997.

• 14) Metcalfe JA, Parkhin J, Campben L, Stacey M, Biggs P, et al.:Accelerated telomere shortening inataxia telangiectasia. Nature Genet. 13:350-353, 1996.

• 15) Pandita TK, Pathak S, Geard CR:Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. cell Genet. 71:86-93, 1995.
  pubmed

• 16) Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, et al.:Positional cloning of the gene for Nijmegen breakage syndrome. Nat. Genet. 19:179-181, 1998.

• 17) Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, et al.:Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. cell 93:467-476, 1998.
  pubmed

• 18) Oexle K, Zwirner A, Freudenberg K, Kohlschutter A, Speer A:Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy. Pediatr. Res. 42:226-231, 1997.
  pubmed

• 19) Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, et al.:Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:661, 1993.
  pubmed

• 20) Sikora E, Radziszewska E, Kmiec T, Maslinska D:The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging. Acta Biochim. Pol. 40:269-272, 1993.
  pubmed

• 21) Salvitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, et al.:A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995.

• 22) Fukuchi K, Tanaka K, Nakura J, Kumahara Y, Uchida T, et al.:Elevated spontaneous mutation rate in SV40-transformed Werner syndrome fibroblast cell lines. Somat. cell Mol. Genet. 11:303-308, 1985.
  pubmed

• 23) 名倉 潤, 叶 林, 森島淳之, 三木哲郎:ヘリカーゼ変異と早老症-転写異常症候群-. 最新医学 53(9):2110-2117, 1998.
  Medical*Online

• 24) Cleaver JE:DNA repair deficiencies and cellular senescence are unrelated in xeroderma pigmentosum cell lines. Mech. Ageing. Dev. 27:189-196, 1984.
  pubmed

• 25) Holliday R, Thompson KV:Genetic effects on the longevity of cultured human fibroblasts. III. Correlations witn altered glucose-6-phosphate dehydrogenase. Gerorntology 29:89-96, 1983.

• 26) Hoehn H, Salk D:Clonal analysis of stable chromosome rearrangements in Bloom's syndrome fibroblasts. Cancer Genet. Cytogenet. 11:405-415, 1984.
  pubmed

• 27) Morrow DM, Tagle DA, Shiloh Y, Conins FS, Hieter P:TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionany related to the yeast checkpoint gene MEC1. Cell 82:831-840, 1995.

• 28) Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, et al.:TEL1, a gene involved in controlling telomere length in S. cerevisiae, is hornologous to the human ataxia telangiectasia gene. Cell 82:823-829, 1995.

• 29) Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, et al.:Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47:482-486, 1998.
  pubmed

• 30) Chang E, Harley CB:Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 92:11190-11194, 1995
  pubmed

P.153 掲載の参考文献

• 1) Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al.:Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol(TRAP) . Methods cell Sci. 17:1-15, 1995.

• 2) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J, Immunol. 155:3711-3715, 1995.
  pubmed

• 3) Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, et al.:Detection of telomerase activity in malignant and nonmalignant skin conditions. J, Invest. Dermatol. 106 759-765, 1996.
  pubmed

• 4) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:Telomerase activity in human intestine. Int. J. Onc. 9:453-458, 1996.

• 5) Ramirez RD, Wright WE, Shay JW, Taylor RS:Telomerase activity concelltrates in the minitoticany active segments of human hair fonicles. J, Invest. Dermatol. 108:113-117, 1997.
  pubmed

• 6) Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, et al.:Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92:12343-12346, 1995.
  pubmed

• 7) Holt SE, Wright WE, Shay JW:Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16:2932-2939, 1996.
  pubmed

• 8) Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, et al.:Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
  pubmed

• 9) Yamada O, Oshimi K, Motoji T, Miaoguchi H:Telometric DNA in normal and leukemic blood cells. J. Clin. Invest, 95:1117-1123, 1995.

• 10) Weng NP, Levine BL, June CH, Hodes RJ:human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl Acad. Sci. USA 92:11091-11094, 1995.
  pubmed

• 11) Monteiro J, Batliwalla F, Ostrer H, Gregersen PK:Shortened telomeres in clonany expanded CD28+CD8+T cells imply a replicative history that is distinct from their CD28+CD8+counterparts. J. Immunol. 156:3587-3590, 1996.
  pubmed

• 12) Weng NP, Granger L, Hodes RJ:Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl Acad. Sci. USA 94:10827-10832, 1997.

• 13) Palmer LD, Weng N, Levine BL, June CH, Lane HC, et al.:Telomere length, telomerase activity, and replicative potential in HIV infection:analysis of CD4＋ and CD8＋Tcells from HIV-discordant monozygotic twins. J. Exp. Med. 185:1381-1386, 1997.

• 14) Weng NP, Levine BL, June CH, Hodes RJ:Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:2471-2479, 1996,

• 15) Bodnar AG, Kim NW, Effros RB, Chiu CP:Mechanism of telomerase induction during T cell activation. Exp. cell Res. 228:58-64, 1996.

• 16) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, et al.:Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895 902, 1995.

• 17) Kolquist KA, Enisen LW, Counter CM, Meyerson M, Tan LK, et al.:Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genet. 19:182-186, 1998.

• 18) Norrback K-F, Dahlenborg K, Carlsson R, Roos G:telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88:222-229, 1996.
  pubmed

• 19) Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahata N, et al.:Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum. Genet. 102:397-402, 1998.
  pubmed

• 20) Broccoli D, Young JW, De Lange T:Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92:9082-9086, 1995.
  pubmed

• 21) Igarashi H, Sakaguchi N:Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 219:649-655, 1996.
  pubmed

• 22) Weng NP, Levine BL, June CH, Hodes RJ:Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J. Immunol. 158:3215-3220, 1997.

• 23) Igarashi H, Sakaguchi N: Telomerase activity is iuduced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299-1307, 1997.

• 24) Brousset P, al Saati T, Chaouche N, Zenou RC, Schlaifer D, et al.:Telomerase activity in reactive and neoplastic lymphoid tissues:infrequent detection of activity in Hodgkin's disease. Blood 89:26-31, 1997.
  pubmed

• 25) Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown B, et al.:Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J. Clin. Pathol. 50:110-117, 1997.

• 26) Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO:Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp. cell Res. 231:346-353, 1997.

• 27) De Boer RJ, Noest A:T cell renewal rates, telomerase, and Telomere length shortening. J. Immunol. 160:5832-5837, 1998.
  pubmed

• 28) Yamanishi Y, Hiyama K, Maeda H, Ishioka S, Murakami T, et al.:telomerase activity in rheumatoid synovium correlates, with the mononuclear cell infiltration level and disease aggresiveness of rheumatoid arthritis. J. Rheumatol. 25:214-220, 1998.

• 29) Hiyama K, Ishioka S, Shay JW, Taooka Y, Meada A, et al.:Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. Int. J. Mol. Med. 1:545-549, 1998.

• 30) Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S:Telomerase activity associated with acquisition of malignancy in human coIorectal cancer. Cancer Res, 55:2533-2536, 1995.
  pubmed

• 31) Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, et al.:Detection of telomerase activity inex foliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer 75:548-553, 1997.

• 32) Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, et al.:Telomerase activity in human liver tissues:comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55:2734-2736, 1995.
  pubmed

• 33) Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, et al.:Telomerase activity detected in pancreatic cancer but not benign tumors, Cancer Res. 57:326-331, 1997.

• 34) Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, et al.:Telomerase actiVity in benign and malignant thyroid tumors. Thyroid 7:337-342, 1997.
  pubmed

• 35) Okayasu I, Osakabe T, Fujiwara M, Fukuda II, Kato M, et al.:Significant correlation of telomerase activity in thyroid papinary carcinomas with cell differentiation, proliferation and extrathyroidal extension. Jpn. J. Cancer Res. 88:965-970, 1997.

• 36) Yashima K, Vuitch F, Gazdar AF, Fahey Tr:Telomerase activity in benign and malignant thyroid diseases. Surgery 122:1141-1145, 1997.

• 37) Yang CT, Lee MH, Lan RS, Chen JK:Telomerase activity in pleural effusions:Diagnostic significance. J. Clin. Oncol. 16:567-573, 1998.
  pubmed

• 38) Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, et al.:Telomerase activity in lung cancer cells obtained from bronchial washings. J, Natl. Cancer Inst. 90:684-690, 1998.
  pubmed

P.161 掲載の参考文献

• 1) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

• 2) Sakabe H, Yahata N, Kimura T, Zeng Z, Minamiguchi H, et al.:Human cord blood-derived progenitos are enriched in CD44+CD38-as well as CD34+c-kit- cell population:A correlation between long term culture-initiating cell and telomerase expression. Leukemia 12:728-734, 1998.

• 3) Vaziri H, Dragowaska W, Allsopp RC, Thomas TE, Harley CB, et al.:Evidence for a mitotic clock in human hematopoietic stem cells:Loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91:9857-9860, 1994.

• 4) Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahata N, et al.:Telomere length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. human Genet. 102:397-402, 1998.
  pubmed

• 5) Norrback K-F, Dahlenborg K, Carlsson R, Ross G:Telomerase activity in normal B lymphocytes and Non-Hodgkin's lymphomas. Blood 82:222-229, 1996.

• 6) Broccoli, Young JW, de Lange T:Telomerase activity in normal and malignant hematoPoietic cells. Proc. Natl. Acad. Sci. USA 92:9082-9086, 1995.
  pubmed

• 7) Pan C, Xue B H, Ellis TM, Peace DJ, Diaz MO:Changes in telomerase activity and telomere length during human T lymphocytes senescence. Exp. cell Res. 231:346-353, 1997.

• 8) Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Ando K, et al.:Clinical implications of telomerase activity level in acute leukemia. Clin. Cancer Res. 3:619-625, 1997.

• 9) Takauchi K, Tashiro S, Ohtaki M, Kamada N:Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jpn. J. Cancer Res. 85:127-130, 1994.
  pubmed

• 10) Adamson DAG, King DJ, Hastie NE:Significant telomere shortening in childhood leukemia. Cancer Genet. Cytogenet. 61:204-206, 1992.

• 11) Yamada O, Oshimi K, Motoji T, Mizoguchi H:Telomeric DNA in normal and leukemic blood cells. J. Clin. Invest. 95:1117-1123, 1995.
  pubmed

• 12) Zhang W, Piatyszeck MA, Kobayashi T, Estey E, Andreeff M, et al.:Telomerase activity in human acute myelogenous leukemia:inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res. 2:799-803, 1996.

• 13) Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Kawakubo K, et al.:The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer 79:1552-1560, 1997.
  pubmed

• 14) Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, et al.:Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 23:190-194, 1997.

• 15) Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, et al.:Telomere stability is frequently impaired in high risk groups of ptients with myelodysplatic syndromes. Clin. Cancer Res. (inpress).

P.167 掲載の参考文献

• 1) 檜山桂子, 石岡伸一, 山木戸道郎:肺癌におけるテロメア長変化と遺伝子変異. 「肺癌の予後因子」(小倉 剛, 安光 勉編) , 中山書店, 東京, 1995, p154-161.

• 2) Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, et al.:Alteration in length of telomeric repeats in lung cancer. Lung Cancer 11:29-41, 1994.
  pubmed

• 3) Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, et al.:Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10:937-944, 1995.
  pubmed

• 4) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K et al.:telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902, 1995.
  pubmed

• 5) Ahrendt SA, Yang SC, WU L, Westra WH, Jen J, et al.:Comparison of oncogene mutation detection and telomerase activity for the molecular staging of Non-small cell lung cancer. Clin. Cancer Res. 3:1207-1214, 1997.
  pubmed

• 6) Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, et al.:telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J, Clin, Path-01. 50:110-117, 1997.
  pubmed

• 7) Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, et al.:Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 52:2373-2377, 1997.

• 8) Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, et al.:High telomerase activity in primary lung cancers:association with increased cell proliferation rates and advanced pathologic stage. J. Natl Cancer Inst. 89:1609-1615, 1997.

• 9) Yang CT, Lee MH, Lan RS, Chen JK:Telomerase activity in pleural effusions:Diagnostic significance. J. Clin. Oncol. 16:567-573, 1998.
  pubmed

• 10) Hiyama K, Ishioka S, Shay JW, Taooka Y, Maeda A, et al.:Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. Int. J. Mol. Med. 1:545-549, 1998.
  pubmed

• 11) Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, et al.:Telomerase activity in lung cancer cells obtained from bronchial washings. J. Natl. Cancer Inst. 90:684-690, 1998.
  pubmed

• 12) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

P.177 掲載の参考文献

• 1) Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, et al.:Telomerase activity in human intestine. Int. J. Oncol 9:453-458, 1996.

• 2) Chadeneau C, Hay K, Hirte HW, Ganinger S, Bacchetti S:Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:2533-2536, 1995.

• 3) Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, et al.:Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1:1245-1251, 1995.
  pubmed

• 4) Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, et al.:Telomerase activity in gastric cancer. Cancer Res. 55:3258-3262, 1995.
  pubmed

• 5) Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al.:Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods cell Sci. 17:1-15, 1995.

• 6) Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al.:Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715, 1995.
  pubmed

• 7) Morrison SJ, Prowse KR, Ho P, Weissman IL:Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-216, 1996.
  pubmed

• 8) Hohaus S, Voso MT, Orta LBE, Cavano S, Bellacosa A, et al.:Telomerase activity in human hematopoietic progenitor cells. Haematologica 82:262-268, 1997.

• 9) Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, et al.:Detection of telomerase activity in maliginant and nonmalignant skin condition. J. Invest. Dermatol. 106:756-765, 1996.

• 10) Harle-Bachor C, Boukamp P:Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93:6476-6481, 1996.
  pubmed

• 11) Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, et al.:Telomerase activity in normal human epithelial cells. Oncogene 13:433-439, 1996.
  pubmed

• 12) Kyo S, Takakura M, Kohama T, Inoue M:Telomerase activity in human endometrium. Cancer Res. 57:610-614, 1997.
  pubmed

• 13) Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, et al.:Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. J. Oncol. 6:13-16, 1995.

• 14) Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, et al.:Alterations in telomeric repeat length in lung cancer are associated with loss of heter-ozygosity in p53 and Rb. Oncogene 10:937-944, 1995.

• 15) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific ass ociation of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.

• 16) Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, et al.:Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1:249-255, 1995.
  pubmed

• 17) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, et al.:Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902, 1995.
  pubmed

• 18) Wright WE, Shay JW, Piatyszek MA:Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acid Res. 23:3794-3795, 1995.
  pubmed

• 19) Takubo K, Nakamura K, Izumiya N, Mafune K, Tanaka Y, et al.:Telomerase activity in eso-phageal carcinomas. J. Surg. OncoL 66:88-92, 1997.

• 20) 池口正英, 貝原信明:食道癌における癌巣, 非癌部粘膜のテロメラーゼ活性. 日本臨床 56:1176-1180, 1998.
  Medical*Online

• 21) 丸山保彦, 花井洋行, 金子栄蔵:胃の腸上皮化生, 腺腫, 分化型腺癌におけるテロメア長, テロメラーゼ活性. 日本臨床 56:1186-1189, 1998.
  Medical*Online

• 22) Breslow RA, Shay JW, Gazdar AF, Srivastava S:Telomerase and early detection of cancer:a National Cancer Institute workshop. J. Natl. Cancer Inst. 89:618-623, 1997.
  pubmed

• 23) Engelhardt M, Drullinsky P, Guillem J, Moore MA:Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3:1931-1941, 1997.
  pubmed

• 24) 小川健治, 若杉慎司, 服部隆男・他:胃癌組織におけるテロメラーゼ活性と臨床病理学的諸因子との関連. 日本臨床 56:1194-1198, 1998.

• 25) Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, et al.:Telomerase activity in human liver tissues:comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55:2734-2736, 1995.
  pubmed

• 26) Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, et al.:Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78:232-236, 1996.
  pubmed

• 27) Ohta K, Kanamaru T, Yamamoto M, Saitoh Y:Clinical significance of telomerase activity in hepatocellular carcinoma. Kobe J. Med. Sci. 42:207-217, 1996.
  pubmed

• 28) Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, et al.:Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int. J. Cancer 74:141-147, 1997.
  pubmed

• 29) Ohta K, Kanamaru T, Morita Y, Hayashi Y, Ito H, et al.:Telomerase activity in hepatocellular carcinom as a predictor of postoperative recurrence. J. Gastroenterol. 32:791. . 796, 1997.

• 30) Miura N, Horikawa I, Nishimoto A, Ohmura H, ItoH, et al.:Progressive telomerase shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 93:56-62, 1997.

• 31) Suda T, Isokawa O, Aoyagi Y, Nomoto M, Tsukada K, et al.:Quantitation of telomerase activity in hepatocellular carcinoma:a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 27:402-406, 1998.
  pubmed

• 32) Tsujiuchi T, Tsutsumi M, Kido A, Kobitsu K, Takahama M, et al.:Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats. Jpn. J. Cancer Res. 87:111-1115, 1996.

• 33) Hiyama E, Kodama T, Sinbara K, Iwao T, Itoh M, et al.:Telomerase activityis detected in pancreatic cancer but not in benign tumors. Cancer Res. 57:326-331, 1997.

• 34) Mizumoto K, Suehara N, Muta T, Kitajima S, Hamasaki N, et al.:Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma. J. Gastroenterol. 31:894-897, 1996.
  pubmed

• 35) Iwao T, Hiyama E, Yokoyama T, Tsuchida A, Hiyania K, et al.:Telomerase activity for the preoperative diagnosis of pancreatic cancer. J. Natl. Cancer Inst. 89:1621-1623, 1997.

• 36) Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, et al.:Detection of telomease activity in exfoliated cancer cells in colonic luminal washings and its reIated clinical implications. Br. J. Cancer 75:548-553, 1997.

P.183 掲載の参考文献

• 1) Rhyu MS:Telomeres, telomerase , and immortality. J. Natl Cancer Inst. 87:884-894, 1995.
  pubmed

• 2) Greider CW:Mamamaliam telomere dynamics:healing, fragmentation, shortening and stabilization. Curr. Opin. Genet. Develop. 4:203-211, 1994.

• 3) Greider CW, Blackburn EH:A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331 337, 1989.
  pubmed

• 4) Morin GB:The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. cell 59:521-529, 1989.
  pubmed

• 5) Collins K, Kobayashi R, Greider CW:Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 81:677-686, 1995.
  pubmed

• 6) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLP1;a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997.
  pubmed

• 7) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al.:Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.
  pubmed

• 8) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18:65-68, 1998.
  pubmed

• 9) Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, et al.:Telomerase , cell immortality, and cancer. Cold Spring Harbor Symp. Quant. Biol. 66:1-9, 1994.

• 10) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
  pubmed

• 11) Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, et al.:Correlating telomerase activity levels with human neuroblastoma outcome. Nature Med. 1:249-255, 1995.
  pubmed

• 12) Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, et al.:Telomerase activity in gastric cancer. Cancer Res. 55:3258-3262, 1995.
  pubmed

• 13) Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, et al.:Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87:895-902, 1995.
  pubmed

• 14) Tahara H, Nakanishi T, Kitamoto M, Nakasho R, Shay JW, et al.:Telomerase activity in human liver tissues:Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55:2734-2736, 1995.

• 15) Tahara H, Kuniyasu H, Yasui W, Yokozaki H, Shay J, V, et al.:Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1:1245-1251, 1995.

• 16) Sugino T, Yoshida K, Bolodeoku J, Tarin D, Goodison S:Telomerase activity and its inhibition in benign and malignant breast lesions. J. Pathol. 183:57-61, 1997.
  pubmed

• 17) Sugino T, Yoshida K, Bolodeoku J, Tahara H, Buley I, et al.:Telonlerase activity in human breast cancer and benign breast lesions:Diagnos-tic applications in clinical specimeng. including fineneedle aspirates. Int. J. Cancer 69:301-306, 1996.

• 18) Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, et al.:Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells inurine. Cancer 79:362-369, 1997.

• 19) Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, et al.:Detection of telomerase activity inexfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer 75:548-553, 1997.
  pubmed

• 20) Gorham H, Yoshida K, Sugino T, Marsh G, Manek S, et al.:Telomerase activity in human gynacological malignancies. J. Clin. Pathol. 50:501-504, 1997.

P.189 掲載の参考文献

• 1) Harle-Bachor C, Boukamp P:telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93:6476-6481, 1996.
  pubmed

• 2) Yasumoto S, Kunimura C, Kikuchi K, Tahara H, 0hji H, et al.:Telomerase activity in normal human epithelial cells. Oncogene 13:433-439, 1996.

• 3) Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, et al.:Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106:759-765, 1996.
  pubmed

• 4) Ueda M, Ouhtit A, Bito T, Nakazawa K, Lubbe J, et al.:Evidence for UV-associated activation of telomerase in human skin. Cancer Res. 57:370-374, 1997.
  pubmed

• 5) Kolodka TM, Garlick JA, Taichman LB:Evidence for keratinocyte stern cells in vitro:Long term engraftment and persistence of transgene expres-sion from retrovirus-transduced keratinocvtes. Proc. Natl. Acad. Sci. USA 95:4356-4361, 1998.

• 6) Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, et al.:Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14:239-248, 1996.
  pubmed

• 7) Bickenbach JR, Boukamp P:Epidermal stem cells have little, if any, telomerase activity. J. Invest. Dermatol. 110:543, 1998. (abstract)

• 8) Brash DE, Rudolph JA, Simon JA, Lin A, Mckenna GJ, et al.:A role for sunlight in skin cancer:UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88:10124-10128, 1991.
  pubmed

• 9) Ziegler A, Jonason AS, Leffen DJ, Simon JA, Sharma HW, et al.:Sunburn and p53 in the onset of skin cancer, Nature 372:773-776, 1994.

• 10) Nakazawa H, English D, R and en PL, Nakazawa K, Martel N, et al.:UV and skin cancer:specific p53gene rnutation in normal skin as a biologicanyrelevant exposure measurement. Proc. Natl. Acad. Sci. USA 91:360-364, 1994.

• 11) Ouhtit A, Ueda M, Nakazawa H, Ichihashi M, Dumaz N, et al.:Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients. Cancer Epidemiol. Biomarkers Prev. 6:433-438, 1997.
  pubmed

• 12) Ramirez RD, Wright WE, Shay JW, Taylor RS:Telomerase activity concelltrates in the mitoticanyactive segments of human hair follicles. J. Invest. Dermatol. 108:113-117, 1997.
  pubmed

• 13) Ogoshi M, Le T, Shay JW, Taylor RS:In situhybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J. Invest. Dermatol. 110:818-823, 1998.

• 14) Kanassy M, Martel N, Damour O, Yamasaki H, Nakazawa H:Growth arrest of immortalizedhuman keratinocytes and suppression of telomerase activity by p21wAFI gene expression. Mol. Carcinog. 21:26-36, 1998.

• 15) Prakash H and e M, Balajee AS, Natarajan AT:Induction of telomerase activity by UV-irradiationin Chinese hamster cells. Oncogene 15:1747-1752, 1997.

P.200 掲載の参考文献

• 1) Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M:Telomerase activity in gynecologic tumor. Clin. Cancer Res. 2:2023-2028, 1996.
  pubmed

• 2) Kyo S, Takakura M, Tanakia M, Kanaya T, Inoue M:Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int. J. Cancer 79:66-70, 1998.

• 3) Kyo S, Takakura M, Tanaka M, Murakami K, Saitoh R, et al.:Quantitative difference of telomerase activity among ovarian malignant and premalignant lesions. Clin. Cancer Res. 4:399-406, 1998.
  pubmed

• 4) Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, et al.:Telomerase activity in gastric cancer. Cancer Res. 55:3258-3262, 1995.
  pubmed

• 5) Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, et al.:Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1:249-255, 1995.
  pubmed

• 6) Kyo S, Takakura M, Kohama T, Inoue M:Telomerase activity in human endometrium. Cancer Res. 57:610-614, 1997.
  pubmed

• 7) Tanaka M, Kyo S, Kanaya T, Takakura M, Sagawa T, et al.:Epithelial specific expression of telomerase activity in human endonnetriuin:Correlation with cell proriferation and effect of estrogen. Am. J. Pathol. 153:1985-1991, 1998.

• 8) Kyo S, Takakura M, Tanaka M, Kanaya T, Sag-awa T, et al.:Expression of telomerase activity in human chorion. Biochem. Biophis. Res. Commum. 241;498-503, 1997.

• 9) Kyo S, Takakura M, Ishikawa H, Sasagawa T, Satake S, et al.:Application of telomerase assay for the screening of cervical lesions. Cancer Res. 57:1863-1867, 1997.
  pubmed

• 10) Feng J, Funk WD, Wang SS, Weinrich AAA, Chiu CP, et al.:The RNA component of human telomerase . Science 269:1236-1241, 1995.

• 11) Harrington L, McPhail T, Mar V, Zhou W, Oulton, et al.:A mammalian telomerase-associated protein. Science 275:973-977, 1997.

• 12) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLPI:Agene encoding a proteincomponent of mammalian telomerase is a novelmember of WD repeats family. cell 88:875-884, 1997.

• 13) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, and rews WH, et al.:Telomerase catalyticsubunit homologs from fission yeast and human . Science 277:955-959, 1997.

• 14) Meyerson M, Counter CM, Eaton EN, Enisen LW, Steiner P, et al.:hEST2, the putative humantelomerase catalytic subunit gene, is up-regulatedin tumor cells and during immortalization. cell gO:785-795, 1997.

• 15) Takakura M, Kyo S, Kanaya T, Tanaka M, InoueM:Expression of telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58:1558-1561, 1998.

• 16) Weinrich SL, Pruzan R, Ma L, Ouenette M, TesmerVM, et al.:Reconstitution of human telomerase with the ternplate RNA component hTR and thecatalytic protein suburlit hTRT. Nature Genet. 17:498-502, 1997.

• 17) Nakayama J, Tahara H, Tahara E, Saito M, Nakamnra H, et al.:Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18:65-68, 1998.

• 18) Bodnar AG, Ouenette M, Frolkins M, Holt SE, Chiu CP, et al.:Extension of life-spam by introduction of telomerase into normal human cells. Science 279:349-352, 1998.

• 19) Kyo S, Takakura M, Kanaya T, Inoue M:Expression of telomerase subunits in ovarian Inalignant, premalignant and benign lesions, Int. J. Cancer. (in press) .

• 20) Kanaya T, Kyo S, Takakura M, Ito H, Namiki M, et al.:hTERT is a critical determinant of telomerase activity in renal cell carcinoma. Int. J. Cancer78:539-543, 1998.

• 21) Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, et al.:Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res. 4:1603-1608, 1998
  pubmed

P.209 掲載の参考文献

• 1) Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW:Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18:173-179, 1996.
  pubmed

• 2) Ravindranath N, Dalal R, Solomon B, Djakiew D, Dym M:Loss of telomerase activity during male germ cell differentiation. Endocrinology 138:4026-4029, 1997.
  pubmed

• 3) Kruk PA, Balajee AS, Rao KS, Bohr VA:Telomere reduction and telomerase inactivation during neuronal cell differentiation. Biochem. Bio-phys. Res. Comm. 224:487-492, 1996.

• 4) Woods WG, Lemieux B, Tuchman M:Neuroblas-toma represent distinct clinical-biologic entities:a review and perspective from Quebec neuroblastoma screening project. Pediatrics 88:114-118, 1992.

• 5) Brodeur GM:Molectnar basis for heterogeneity in human neuroblastoma. Eur. J. Cancer 31A:505-510, 1995.
  pubmed

• 6) Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Phatyszek MA, et al.:Correlating telomerase activity levels with human neuroblastoma out-comes. Nature Med. 1:249-255, 1995.

• 7) Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichik-awa T, et al.:Telomerase activity in neuroblastoma:is it a prognostic indicator of clinical behavior? Eur. J. Cancer 33:1932-1936, 1997.

• 8) Evans AE, Gerson J, Schnaufer L:Spontaneous regression of neuroblastoma. Natl. Cancer Inst. Monogr. 44:49-54, 1976.
  pubmed

• 9) Evans AE, Baum E, Chard R:Do infants with stage IV-Sneuroblastoma need treatment? Arch. Dis. Child. 56:271-274, 1981.
  pubmed

• 10) Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, et al.:Comparative genomic hybridization and telomerase activity analysis identify two biologicany different groups of 4S neurob-Iastomas. Br. J. Cancer 77:2223-2229, 1998.

• 11) Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y:Length of telomeric repeats in neur-oblastoma:CorreIation with prognosis and other biological characteristics. JPn. J. Cancer Res. 83:159-164, 1992.

• 12) Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM:Amplification of N-myc in untreated human neuroblastoma correlated with advanced stage. Science 224:1121-1124, 1984.

• 13) Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, et al.:Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res. 52:1780-1785, 1992.
  pubmed

• 14) Friend SH, Ilorowitz JM, Gerber MR, Wnag X-F, Bogenmalm E, et al.:Deletions of a DNAsequence HI retinoblastomas and mesenchymal ttlmors:Organization of the sequence and its encoded protein. Proc. Natl. Acad. Sci. USA 84:9059-9063, 1987.

• 15) Gupta J, Han LP, Wang P, Ganie BL, Bacchetti S:Development of retinoblastoma in the absence of telomerase activity. J. Natl. Cancer Inst. 88:1152-1157, 1996.

• 16) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al.:Specific association of human telomerase activity with immortal cells and cancer Science 266:2011-2015, 1994.
  pubmed

• 17) de Lange T, Shiue L, Myers RM, Cox DR, Nayor SL, et al.:Structure and variability of human chromosome ends. Mon. cell. Biol. 10:518-527, 1990.

• 18) Bove KE, McAdamsn AJ:The nephroblastomatosis complex and its relationship to Wilms' tumor:a clinicopathologic treatise. Perspect. Pediatr. Pathol. 3:185-223, 1976.

• 19) Green DM, D'Angio GJ, Beckwith JB, Breslow NE, Grundy PE, et al.:Wilms tumor. CA Cancer J. Clin. 46:46-63, 1996.
  pubmed

• 20) Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, et al.:Expression of the RNAcomponent of telomerase in Wilms'tumor and nephrogenic rest recapitulates renal embryogenesis. Hum. Pathol. 28:536 542, 1998.

• 21) Bolande RP, Brough AJ, Izant RJJ:Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics 40:272-278, 1967.

• 22) Akmal SM, Yun K, MacLay J, Higami Y, Ikeda T:Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma. Hum. Pathol. 26:846-851, 1995.

• 23) Ulbright TM, Roth LM:Recellt developments in the pathology of germ cell tumors. Semin. Diagn. Pathol. 4:304-319, 1987.
  pubmed

P.218 掲載の参考文献

• 1) Kim NW, Piatyszek MA, Pro, vse KR, Harley CB, , Vest MD , et al.:Specific association of human telomerase activitv, with immortal cells and cancer. Science 266:2011-2015, 1994.

• 2) Mutirangura A, Supiyaphun P, Trirekapan S, Sriuranpong V, Sakuntabhai A, et al.:Telomerase activity in oral letlkoplakia and head and necksquamous cell carcinoma. Cancer Res. 56:3530-3533, 1996.

• 3) Hohaus S, Cavallo S, Benacosa A, Genuardi M, Galli J, et al.:Telomerase activity in human laryngeal squamous cell carcinomas. Clin. Cancer Res. 2:1895-1900, 1996.
  pubmed

• 4) Mao L, El NA, Fan YH, Lee JS, Lippman SM, et al.:Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 56:5600-5604, 1996.

• 5) Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, et al.:Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res. 56:5720-5722, 1996.
  pubmed

• 6) Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, et al.:Telomerase activity in premalignant and malignant lesions of humali oral mucosa. Cancer Epidemiol Biomarkers Prev. 6:413-420, 1997,

• 7) Cheng RY, Yuen PW, Nichons JM, Zheng Z, WeiVV, et al.:Telomerase activation in nasopharyngeal carcinomas. Br. J. Cancer 77:456-460, 1998.

• 8) Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, et al.:Telomerase activity:a marker to distinguish fonicular thyroid adenoma from carcinoma. Cancer Res. 57:2144-2147, 1997.
  pubmed

• 9) Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, et al.:Telonlerase activity in benign and malignant thyroid tunlors. Thyroid 7:337-342, 1997.
  pubmed

• 10) Okayasu I, Osakabe T, Fujiwara M, Fukuda H, Kato M, et al.:Significant correlation of telomerase activity in thyroid papinary carcinomas with cell differentiation, proliferation and extrathyroidal extension. JPn. J. Cancer Res. 88:965-970, 1997.
  pubmed

• 11) Brousset P, al ST, Chaouche N, Zenou RC, Schlaifer D, et al.:Telomerase activity in reactive and neoplastic lymphoid tissues:infrequent detection of activity in Hodgkin's disease. Blood 89:26-31, 1997.

• 12) Saji M, Westra WH, Chen H, Umbricht CB, Tuttle RM, et al.:Telomerase activity in the differential diagnosis of papinary carcinoma of the thyroid. Surgery l22:1137-1140, 1997.

• 13) Yashima K, Vuitch F, Gazdar AF, Fahey Tr:Telomerase activity in benign and malignant thyroid diseases. Surgery 122:1141-1145, 1997.

• 14) Cheng AJ, Lin JD, Chang T, Wang TC:Telomerase activity in benign and malignant human thyroid tissues. Br. J. Cancer 77:2177-21801998.
  pubmed

• 15) Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K:Elevated levels of telonlerase activity in malignant pheochromocytoma. Cancer 82:176-179, 1998.
  pubmed

• 16) Kinoshita H, Ogawa O, Mishina M, Oka H, Okumura K, et al.:Telomerase activity in adrenal cortical tumors and pheochronnocytomas with reference to clinic opathologic features, Urol. Res, 26:29 32, 1998.

• 17) Schwartz HS, Juliao SF, Sciadini MF, Miner LK, Butler MG:Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 75:1094-1099, 1995.

• 18) Butler MG, Dahir GA, Hedges LK, Jnliao SF, Sciadini MF, et al.:Cytogenetic, telomere, and telonlerase studies in five surgicany managed luni-bosacral chordomas. Cancer Genet. Cytogenet. 85:51. 57, 1995.

• 19) Engelhardt M, Albanen J, Dnnlinsky P, Han W, Guillem J, et al.:Relative contribution of normal and neoplastic cells determines telomerase activity and telomere Iength in primary cancers of the prostate, colon, and sarcoma. Clin. Cancer Res. 3:1849 1857, 1997.

• 20) Schwartz HS, Dahir GA, Butler MG:Telomere reduction in giant cell tunlor of bone and with aging. Cancer Genet. Cytogenet. 71:132-138, 1993.
  pubmed

• 21) Schneider Stock R, Epplen C, Radig K, Oda Y, Drane H, et al.:On telomere shortening in soft tissue tumors. J. Cancer Res. Clin. Oncol. 124:165-171, 1998.

• 22) Chang E, Harley CB:Telomere length and re-plicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 92:11190-11194, 1995.

• 23) Langford LA, Piatyszek MA, Xu R, Schold Jr. SC, Shay JW:Telomerase activity in human brain tumours. Lancet 346:1267-1268, 1995.

• 24) Langford LA, Piatyszek MA, Xu R, Schold SJ, Wright, VE, et al.:Telomerase activity in ordinary meningiomas predicts poor outcome. Hurn. Pathol. 28:416-420, 1997.

• 25) Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, et al.:Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am. J. Pathol. 150:1159-1164, 1997.
  pubmed

• 26) DeMasters BK, Markham N, Lillehei KO, Shroyer KR:Differential telomerase expression in human primary intracranial tumors. Am. J. Clin. Pathol. 107:548-554, 1997.
  pubmed

• 27) Nakatani K, Yoshimi N, Mori H, Yoshimura S, Sakai H, et al.:The significant role of telomerase activity in human brain tumors. Cancer 80:471-476, 1997.
  pubmed

• 28) Morii K, Tanaka R, Onda K, Tsumanuma I, Yoshimura J:Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas. Biochem. Biophys. Res. Commun. 239:830-834, 1997,
  pubmed

• 29) Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemnra Y, et al.:Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res. 58:2117-2125, 1998.

• 30) Zhu LS, Anthony EC, Greider CW, Black PM:Telornerase activity in human gliomas. Neurosurgery 42:1120-1124, 1998.

• 31) Sano T, Asai A, Mishima K, Fujimaki T, Kirino T:Telomerase activity in 144 brain tumours. Br. J. Cancer 77:1633-1637, 1998.
  pubmed

• 32) Chomg EY, Lam PY, Poon W-S, NG H-K:Telomerase expression in gliomas including the nonastrocytic tumors. Hum. Pathol. 29:599-603, 1998.

• 33) Nurnberg P, Thiel G, Weber F, Epplen JT:Changes of Telomere lengths in human intracranial tumours. Hum. Genet. 91:190-192, 1993.
  pubmed

• 34) Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, et al.:Telomerase activity:a prevalent marker of malignant human prostate tissue. Cancer Res. 56:218-222, 1996.
  pubmed

• 35) Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, et al.:Telomerase activity in primary prostate cancer. J. Urol. 157:1161-1165, 1997.
  pubmed

• 36) Scates DK, Muir GH, Venitt S, Carmichael PL:Detection of telomerase activity in human prostate:a diagnostic marker for prostatic cancer? Br. J. Urol. 80:263-268, 1997.
  pubmed

• 37) Kanakury BV, Brien TP, Lowry CV Muraca PJ, Fisher HA, et al.:Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas. Diagn. Mol. Pathol. 6:192198, 1997.

• 38) Takahashi C, Miyagawa I, Kuinano S, Oshimura M:Detection of telomerase activity in prostate cancer by needle biopsy. Eur. Urol. 32:494-498, 1997.

• 39) Zhang W, Kapusta LR, Slingerland JM, Klotz LH:Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res. 58:619-621, 1998.
  pubmed

• 40) Lin Y, Uemura H, Fujinami K, Hosaka M, Iwasaki Y, et al.:Detection of telomerase activity in prostate needle-biopsy samples. Prostate 36:121 128, 1998.

• 41) Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G:Telomerase activity in human renal cell carcinoma. Oncogene 13:161-166, 1996.
  pubmed

• 42) Kinoshita H, Ogawa O, Mitsumori K, Kakehi Y, Terachi T, et al.:Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. J. Urol. 159:245-251, 1998.

• 43) Rohde V, Sattler HP, Oehlenschlager B, Forster S, Zwergel T, et al.:Genetic changes and telomerase activity in human renal cell carcinoma. Clin. Cancer Res. 4:197-202, 1998.
  pubmed

• 44) Mehle C, Lindblom A, Ljungberg B, Stenling R, Roos G:Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int. J. Oncol. 13:289-295, 1998.
  pubmed

• 45) Yoshida K, Sakamoto S, Sumi S, Higashi Y, Kitahara S:Telomerase activity in renal cell carcinoma. Cancer 83:760-766, 1998.
  pubmed

• 46) Holzmann K, Blin N, Welter C, Zang KD, Seitz G, et al.:Telomeric associations and loss of telomeric DNA repeats in renal tumors. Genes, Chromosomes & Cancer 6:178-181, 1993.
  pubmed

• 47) Mehle C, Ljungberg B, Roos G:Telomere shortening in renal cell carcinoma. Cancer Res. 54:236-241, 1994.
  pubmed

• 48) Dahse R, Fiedler W, Ernst G, Kosmehl H, Schilichter A, et al.:Changes in telomere lengths in renal cell carcinomas. Cell. Mol. Biol. 42:477-485, 1996.
  pubmed

• 49) Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, et al.:Detection of telomerase activityin human cells and tumors by a telomeric repeat amplification protocol(TRAP) . Methods Cell Sci. 17:1-15, 1995.

IV. 新薬開発

P.227 掲載の参考文献

• 1) Nakamura TM, Morin GB, Chapman KB, Weinrich SL, and rews XVH, et al.:telomerase catalytic subunit homologs from fission yeast and human . Science 277:955-959, 1997.

• 2) Meyerson M, Counter CM, Eaton EN, Enisen LW, Steiner P, et al.:hEST2, the putative human telomerase catalytic subunit gene, is up regulated in tumor cells and during immortalization. Cell 90:785-795, 1997.

• 3) Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, et al.:Human telomerase contain sevolutionarily conserved catalytic and structural subunits. Genes Dev. 11:3109-3115, 1995.

• 4) Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al.:Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genet. 18:65-68, 1998.
  pubmed

• 5) Feng J, Funk WD, Wang SS, Weinrich SL, AvilionAA, et al.:The RNA component of human telomerase. Science 269:1236-1241, 1995.
  pubmed

• 6) Weinrich SL, Pruzarl R, Ma L, Ouenette M, TesmerVM, et al.:Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17:498-502, 1997.

• 7) Strahl C, Blackburn EH:Effects of reverse transcriptase inhibitors on telomerase length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16:53-63, 1996.
  pubmed

• 8) Fletcher TM, Salazar M, Chen SF:Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. Biochemistry 35:15611-15617, 1996.
  pubmed

• 9) Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayevsky AA, et al.:Reverse-transcriptase inhibitors supress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Lett. 389:115-118, 1996.

• 10) Gomez DE, Tejera AM, Plivero OA:Irreversible telomere shortening by 3'azido-2', 3'-dideoxythymidine(AZT) treatment. Biochem. Biophys. Res. Commun. 246:107-110, 1998.

• 11) Melana SM, Holland JF, Pogo BJ:Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res. 4:693-696, 1998.

• 12) Pai RB, Pai SB, Kukhanova M, Dntschman GE, Guo X, et al.:Telornerase from human leukemia cells:properties and its interaction with deoxynucleoside analogues. Cancer Res. 58:1909-1913, 1998.

• 13) Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR:Inhibition of human telomerase activity by peptide nucleic-acid. Nature Biotech. 14:615619, 1996.

• 14) Kanazawa Y, Ohkawa K, Ueda K, Mita E, Takehara T, et al.:Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 225:570-576, 1996.
  pubmed

• 15) Yamakuchi M, Nakata M, Kawahara K, Kitajima I, Maruyama I:New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcimona cell lines. Cancer Lett. 119:213・219, 1997.

• 16) Sogawa K, Sumida T, Harnakawa H, Yamada T, Matsumoto K, et al.:Inhibitory effect of a marine microalgal polysaccharide on the telomerase activity in K562 cells. Res. Commun. Mol. Pathol. Phamacol. 99:259-265, 1998.

• 17) Ku WC, Cheng AJ, Wang TC:Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem. Biophys. Res. Commun. 241:730-736, 1997.
  pubmed

• 18) Li H, Zhao n, Funder JVV, Liu JP:Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem, 272:16729-16732, 1997.

• 19) Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F:TLPI:a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997.

• 20) Prowse KR, Greider CW:Developmental and tissue specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92:4818-4822, 1995.
  pubmed

• 21) Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, et al.:Essential role of motlsetelomerase in highly proliferative organs. Nature 392:569-574, 1998.
  pubmed

• 22) Bodnar AG, Ouenette M, Frolkis M, Holt SE, Chiu CP, et al.:Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352, 1998.